Thakur Mili, Strug Michael R, De Paredes Jessica Garcia, Rambhatla Anupama, Munoz Marcos I Cordoba
Reproductive Genomics Program, The Fertility Center, 3230 Eagle Park Dr. NE, Suite 100, Grand Rapids, MI, 49525, USA.
Department of Obstetrics, Gynecology and Reproductive Biology, College of Human Medicine, Michigan State University, Grand Rapids, MI, USA.
J Ultrasound. 2022 Jun;25(2):379-386. doi: 10.1007/s40477-021-00574-y. Epub 2021 Mar 2.
To objective of this study is to discuss the ultrasonographic technique to diagnose uterine enhanced myometrial vascularity/arteriovenous malformation (EMV/AVM) and differentiate it from retained products of conception. The study also reviews the management and outcome of EMV/AVM.
We present a series of three women who developed EMV after early pregnancy loss and a control case of incomplete abortion, where colour Doppler ultrasound was used to distinguish retained products of conception from features of EMV. Clinical status and imaging findings, including peak systolic velocity (PSV), were used for the initial risk stratification of the patients. All cases with EMV/AVM were managed expectantly with serial ultrasound imaging and trending human chorionic gonadotropin levels. The patient with retained products of conception was managed by hysteroscopy and curettage.
In all cases, presentation was suggestive of incomplete abortion with retained products of conception. However, colour Doppler ultrasound demonstrated hypoechoic areas within the endometrium extending into the myometrium with a high maximum PSV. In the control case, colour Doppler ultrasound noted a heterogeneous area in the left uterine cavity; however, vascular flow in this area was distinct from the endometrium, suggesting retained products of conception. All three women with EMV were managed expectantly with close monitoring and good outcomes.
In patients with early pregnancy loss and bleeding or persistently elevated human chorionic gonadotropin levels, clinical status and appropriate use of ultrasound imaging with colour Doppler, including PSV measurement, can assist in recognition of EMV/AVM. Expectant management with serial ultrasound evaluation is a safe treatment option for EMV/AVM with low PSV and can minimise complications such as need for blood transfusion, uterine artery embolization, and hysterectomy.
本研究的目的是探讨超声技术诊断子宫肌层血管增强/动静脉畸形(EMV/AVM)并将其与妊娠物残留相鉴别。本研究还回顾了EMV/AVM的管理及结局。
我们报告了3例早期妊娠丢失后发生EMV的女性病例以及1例不全流产对照病例,采用彩色多普勒超声将妊娠物残留与EMV的特征相区分。临床状况及影像学表现,包括收缩期峰值流速(PSV),用于患者的初始风险分层。所有EMV/AVM病例均采用连续超声成像及动态监测人绒毛膜促性腺激素水平进行期待治疗。妊娠物残留患者采用宫腔镜刮宫术治疗。
所有病例临床表现均提示不全流产伴妊娠物残留。然而,彩色多普勒超声显示子宫内膜内低回声区延伸至肌层,PSV最高值较高。在对照病例中,彩色多普勒超声显示子宫左侧宫腔内有一不均匀区域;然而,该区域的血流与子宫内膜不同,提示妊娠物残留。所有3例EMV女性患者均通过密切监测进行期待治疗,结局良好。
对于早期妊娠丢失且有出血或人绒毛膜促性腺激素水平持续升高的患者,临床状况及合理应用彩色多普勒超声成像,包括测量PSV,有助于识别EMV/AVM。对于PSV较低的EMV/AVM,采用连续超声评估进行期待治疗是一种安全的治疗选择,可将输血、子宫动脉栓塞及子宫切除术等并发症降至最低。